Generic LymePak Availability
Last updated on Jun 11, 2025.
LymePak is a brand name of doxycycline, approved by the FDA in the following formulation(s):
LYMEPAK (doxycycline hyclate - tablet;oral)
-
Manufacturer: CHARTWELL PHARMA
Approval date: June 15, 2018
Strength(s): EQ 100MG BASE (discontinued) [RLD]
All of the above formulations have been discontinued.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of LymePak. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: Generic Drug FAQ.
More about LymePak (doxycycline)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy or Breastfeeding
- En español
Related treatment guides
Related/similar drugs
Rocephin
Rocephin (ceftriaxone) is used to treat bacterial infections, including severe or life-threatening ...
Vibramycin
Vibramycin is used for acne, actinomycosis, amebiasis, anthrax, anthrax prophylaxis, bacterial ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Ceftin
Ceftin (cefuroxime) is an antibiotic used to treat many kinds of bacterial infections. Includes ...
Monodox
Monodox is used for acne, actinomycosis, amebiasis, anthrax, anthrax prophylaxis, bacterial ...
Doryx
Doryx is used for acne, actinomycosis, amebiasis, anthrax, anthrax prophylaxis, bacterial ...
Oracea
Oracea is used to treat inflammation associated with rosacea in adults. Learn about side effects ...
Cefotaxime
Cefotaxime is used for bacteremia, bone infection, cesarean section, CNS Infection, endometritis ...
Cefuroxime
Cefuroxime is used for bacterial infection, bladder infection, bone infection, bronchitis ...
Erythromycin
Erythromycin is a macrolide antibiotic used to treat bacterial infections. Includes erythromycin ...
Glossary
| Term | Definition |
|---|---|
| Drug Patent | A drug patent is assigned by the U.S. Patent and Trademark Office and assigns exclusive legal right to the patent holder to protect the proprietary chemical formulation. The patent assigns exclusive legal right to the inventor or patent holder, and may include entities such as the drug brand name, trademark, product dosage form, ingredient formulation, or manufacturing process A patent usually expires 20 years from the date of filing, but can be variable based on many factors, including development of new formulations of the original chemical, and patent infringement litigation. |
| Drug Exclusivity | Exclusivity is the sole marketing rights granted by the FDA to a manufacturer upon the approval of a drug and may run simultaneously with a patent. Exclusivity periods can run from 180 days to seven years depending upon the circumstance of the exclusivity grant. |
| RLD | A Reference Listed Drug (RLD) is an approved drug product to which new generic versions are compared to show that they are bioequivalent. A drug company seeking approval to market a generic equivalent must refer to the Reference Listed Drug in its Abbreviated New Drug Application (ANDA). By designating a single reference listed drug as the standard to which all generic versions must be shown to be bioequivalent, FDA hopes to avoid possible significant variations among generic drugs and their brand name counterpart. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
